Clinical Trials Logo

Filter by:
NCT ID: NCT04519840 Completed - Clinical trials for Pelvic Floor Disorders

Diastasis Recti Abdominis Association With Sacroiliac Joint and Pelvic Floor Dysfunction in Postpartum C-section Women

Start date: December 15, 2020
Phase:
Study type: Observational [Patient Registry]

Purpose: The purpose of the proposed study is to examine the ability of diastasis recti abdominis to predict outcomes of Sacroiliac joint dysfunction and pelvic floor dysfunction. - Sample: The study will use a purposive sampling to select 120 subjects, ages 18-45, in the postpartum period between 12 weeks and 48 weeks. All subjects should have resided in the UAE minimum of 6 months prior to taking part in the study. Data analysis: - The age range of the subjects as well as the mean age with standard deviation will be determined. - Data will be analyzed using Multivariate Linear Regression Analysis for the primary research question. - For the Ssecondary research questions will include difference in DRA will be analyzed byas below: - SIJ Dysfunction (logistic regression-Odds ratio) - PFDI (Low, Moderate, High) (ANOVA/Kruskal Wallace Wallis Test) - Pelvic Fascia excursion (Low, Moderate, High). (ANOVA/Kruskal Wallace Wallis Test)

NCT ID: NCT04510207 Completed - COVID-19 Clinical Trials

A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above

COVID-19
Start date: July 16, 2020
Phase: Phase 3
Study type: Interventional

This is a multicenter, randomized, double blind, parallel placebo controlled, phase 3 clinical trial to evaluate the protective efficacy, safety and immunogenicity of inactivated SARS-CoV-2 vaccines in healthy population 18 years old and above.

NCT ID: NCT04505306 Completed - Clinical trials for Diabetic Macular Edema

Short-pulse Subthreshold vs Infrared Micropulse for Diabetic Macular Edema

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

When applied according to manufacturer recommendations, short-pulse system may yield more temporary reduction in edema while infrared micropulse system may yield slightly better functional outcomes.

NCT ID: NCT04497597 Completed - Clinical trials for Rheumatoid Arthritis (RA)

A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis

UPHOLD
Start date: October 16, 2020
Phase:
Study type: Observational

Rheumatoid Arthritis (RA) is an inflammatory disease of the joints causing pain, stiffness, swelling and loss of joint function. Despite the range of treatment options for RA steadily increasing, many patients remain sub-optimally managed, with sustained clinical remission rarely achieved. This study will assess the treatment patterns, achievement of treatment targets and maintenance of response. Upadacitinib is a drug approved for the treatment of moderately to severely active rheumatoid arthritis. Adult participants with moderate to severe RA who have been prescribed upadacitinib by their physicians will be enrolled. Approximately, 1660 participants will be enrolled this study, worldwide. Participants will not receive Upadacitinib as part of this study, but will be followed for response to treatment for up to 24 months. There may be higher burden for participants in this trial compared to their standard of care. Participants will attend regular visits, every 3 months, during the course of the study at a hospital or clinic and will be asked to provide additional information by questionnaire at each visit.

NCT ID: NCT04484324 Completed - Clinical trials for Mechanical Neck Pain

Optimal Duration of Stretching Exercise in Patients With Chronic Mechanical Neck Pain

Start date: July 5, 2020
Phase: N/A
Study type: Interventional

controversy remains about the stretching parameters needed to achieve a particular goal or treatment outcome. In clinical practice, multiple stretching techniques are used; nevertheless, there is no evidence-based agreement on the most effective parameters. One of these parameters, that might be affecting the treatment outcome the most, is the stretching duration, thus far there is a little agreement on the optimal stretching duration. This non agreement in exact stretching parameters is obvious between authors and researchers in the field of muscle energy techniques (MET) as well as those who have used and advocate various durations for the passive stretch that follows the contraction phase in MET.

NCT ID: NCT04477213 Completed - COVID19 Clinical Trials

Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers.

Start date: September 11, 2021
Phase:
Study type: Observational

The investigators propose to conduct a retrospective study to define and quantify the variable occupational and non-occupational risk among various HCWs who got COVID-19 . The investigators aim to determine the rates of acquisition of COVID-19, in the context of level of exposure , adequacy of PPE use and other infection control measuresrecommended for COVID-19 and also to define the risk of secondary disease transmission to other household members of HCWs.

NCT ID: NCT04475757 Completed - Postoperative Pain Clinical Trials

Ultra Sounded Guided Posterior Transverse Abdominis Plane & Lateral FEMORAL Cutaneous Nerve Blocks Analgesia Post Hip Hemiarthroplasty

Start date: May 15, 2018
Phase:
Study type: Observational

COMBINED ULTRASOUND GUIDED POSTERIOR TRANS VERSUS ABDOMINAL PLANE & LATERAL FEMORAL CUTANEOUS NERVE BLOCKS FOR POSTOPERATIVE ANALGESIA AFTER HIP HEMIARTHROPLASTIC SURGERY

NCT ID: NCT04473170 Completed - Clinical trials for Coronavirus Disease 2019 (COVID-19)

Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19

SENTAD-COVID
Start date: April 4, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

SENTAD-COVID Study is an adaptive, prospective, multicentric, open-label, and randomized controlled clinical trial involving hospitalized adult patients with confirmed coronavirus disease 2019 (COVID-19) infection during the outbreak in Abu Dhabi, 2020. The patients were randomly allocated in a parallel assignment involving two groups of participants: Group A (Experimental arm): autologous non-hematopoietic peripheral blood stem cells (NHPBSC) therapy as add-on COVID-19 standard care, or Group B (No investigational intervention arm): COVID-19 standard care. Standard care is defined as per the "UAE National Guidelines for Clinical Management and Treatment of COVID-19". SENTAD-COVID Study was conducted in the Sheikh Khalifa Medical City (SKMC) of Abu Dhabi, as Primary Care Clinical Trial Unit, while the cell processing and investigational product formulation were completed by Abu Dhabi Stem Cells Center (ADSCC), according to Good Laboratory Practices (GLPs) and Good Manufacturing Practices (GMPs).

NCT ID: NCT04449367 Completed - Clinical trials for Post Operative Analgesia

ERECTOR SPINAE BLOCK AFTER THORACIC SPINE SURGERY

SPINE
Start date: August 26, 2018
Phase:
Study type: Observational [Patient Registry]

the effectiveness of ultrasound guided erector spinae plane block in patients undergoing thoracic spine sugery

NCT ID: NCT04441801 Completed - Clinical trials for Physical and Rehabilitation Medicine

Optimal Duration of Stretching of the Hamstring Muscle Group

Start date: June 5, 2020
Phase: N/A
Study type: Interventional

OBJECTIVE: To explore the effect of variable stretching intervals on neural function and ROM. DESIGN: Randomized controlled trial Participants: In this trial, 168 participants diagnosed with tight hamstring muscles (defined as the inability to extend the knee to less than 20° of knee flexion) were randomly assigned to the control group or one of the 3 intervention groups Interventions: The three experimental groups was stretched for 15, 30, and 60 seconds, respectively the control group did not stretch Main Outcome Measures: The neurophysiological outcome measures included peak to peak somatosensory evoked potential for dermatomes L3,L4,L5, and S1. Secondary outcome measures included knee ROM. All outcome measures were assessed immediately after the treatment session and 24 hours after the treatment session.